Zylox-Tonbridge (HKG: 2190), a Chinese specialist in medical devices, has announced a series of product marketing approvals from the United Arab Emirates (UAE) Ministry of Health and Prevention. The company received approval for a total of five products, including the ZENFluxion Drug-coated PTA Balloon Catheter, ZENFlow HP PTA Balloon Catheter, ZENFlow PTA Balloon Catheter, ZENFlex Peripheral Stent System, and the ZENFLEX Pro Peripheral Drug-eluting Stent System.
These approvals represent a significant milestone for Zylox-Tonbridge, marking the company’s first foray into the Gulf region. The Middle East is emerging as a pivotal overseas market for Chinese device manufacturers, and this development underscores Zylox’s growing global footprint. With these new approvals, Zylox now markets its products in over 20 countries worldwide, strengthening its position in the international medical device market.
The expansion into the UAE and the broader Middle East market is a strategic move for Zylox-Tonbridge, as it seeks to capitalize on the growing demand for advanced medical devices in the region and establish itself as a key player in the global healthcare industry.- Flcube.com
